36C26122Q0643-BLOOD SFVAMC ESTIMATED QUANTITY.pdf

Item # Description/Part Number* Qty/YR

Base Year: 10/01/2022-09/30/2023 Leukoc-poor RBC 1400 Red Cells, Washed 15 Red Cells, Irradiated 100 Red Cells, Autologous 5 Red Cells, Thawed 6 Red Cells, Directed 5 Fresh Frozen Plasma 300 Platelet, LVDS 405 Platelet, PRT 5 Pooled Cryo 70 RhIg 2 Screening for negative blood per antigen 100 Irradiate Units 100 Screening for CMV negative blood 10 Antibody Identification 25 Enzyme Panel 20 Select Cell Panel 20 Absorption/Elution with Panel 15 Inhibition/Panel 5 Chloroquine Treatment 5 Extended Phenotyping 25

Phenotyping, Whole Blood or Red Cell Mass 28

Plateletpheresis, crossmatched (unit) 10

Screening for historically antigen Negative blood per antigen 180

Crossmatched Platelet Donor Recruitment 30 Transportation charge for STAT orders 200 STAT off hours surcharge 40 Volume-reduced cellular products 10 DTT (Dithiothreitol) screen 25 DTT (Dithiothreitol) panel 10

RBC Genotype (HEA BeadChip Assay or similar) 5

Drug study 5 Direct Antiglobulin Test 25 Adsorption Auto 15 Adsorption Allo 10

Adsorption REST (cold auto) 1 ABO/Rh grouping 5 Antibody Screen 5 PLT Crossmatch (test) 15 Plateletpheresis, HLA matched 5 PLT Antibody screen 8 HLA Antibody screen 8

Patient HLA (A,B) typing for HLA PLT selection 8

HPA-1a Antigen screen 1 Molecular genotype (HPA) 1 SARS-CoV-2 Convalescent Plasma 10 SUBTOTAL (Products)

Ordering Period 1: 10/1/23-9/30/24 Leukoc-poor RBC 1400 Red Cells, Washed 15 Red Cells, Irradiated 100 Red Cells, Autologous 5 Red Cells, Thawed 6 Red Cells, Directed 5 Fresh Frozen Plasma 300 Platelet, LVDS 405 Platelet, PRT 5 Pooled Cryo 70 RhIg 2 Screening for negative blood per antigen 100 Irradiate Units 100 Screening for CMV negative blood 10 Antibody Identification 25 Enzyme Panel 20 Select Cell Panel 20 Absorption/Elution with Panel 15 Inhibition/Panel 5

Crossmatched Platelet Donor Recruitment 30

Transportation charge for STAT orders 200 STAT off hours surcharge 40 Volume-reduced cellular products 10

Drug study 5 Direct Antiglobulin Test 25 Adsorption Auto 15 Adsorption Allo 10 Adsorption REST (cold auto) 1 ABO/Rh grouping 5 Antibody Screen 5 PLT Crossmatch (test) 15 Plateletpheresis, HLA matched 5

HPA-1a Antigen screen 1 Molecular genotype (HPA) 1 SARS-CoV-2 Convalescent Plasma 10 SUBTOTAL (Products)

Ordering Period 2: 10/1/24-9/30/25 Leukoc-poor RBC 1400 Red Cells, Washed 15 Red Cells, Irradiated 100 Red Cells, Autologous 5 Red Cells, Thawed 6 Red Cells, Directed 5 Fresh Frozen Plasma 300 Platelet, LVDS 405 Platelet, PRT 5 Pooled Cryo 70 RhIg 2 Screening for negative blood per antigen 100 Irradiate Units 100 Screening for CMV negative blood 10 Antibody Identification 25 Enzyme Panel 20

Select Cell Panel 20 Absorption/Elution with Panel 15 Inhibition/Panel 5

Crossmatched Platelet Donor Recruitment 30 Transportation charge for STAT orders 200 STAT off hours surcharge 40 Volume-reduced cellular products 10

Drug study 5 Direct Antiglobulin Test 25 Adsorption Auto 15 Adsorption Allo 10 Adsorption REST (cold auto) 1 ABO/Rh grouping 5 Antibody Screen 5 PLT Crossmatch (test) 15 Plateletpheresis, HLA matched 5

HPA-1a Antigen screen 1 Molecular genotype (HPA) 1 SARS-CoV-2 Convalescent Plasma 10 SUBTOTAL (Products)

Ordering Period 3: 10/1/25-9/30/26 Leukoc-poor RBC 1400 Red Cells, Washed 15 Red Cells, Irradiated 100 Red Cells, Autologous 5 Red Cells, Thawed 6

Red Cells, Directed 5 Fresh Frozen Plasma 300 Platelet, LVDS 405 Platelet, PRT 5 Pooled Cryo 70 RhIg 2 Screening for negative blood per antigen 100 Irradiate Units 100 Screening for CMV negative blood 10 Antibody Identification 25 Enzyme Panel 20 Select Cell Panel 20 Absorption/Elution with Panel 15 Inhibition/Panel 5

Crossmatched Platelet Donor Recruitment 30 Transportation charge for STAT orders 200 STAT off hours surcharge 40 Volume-reduced cellular products 10

Drug study 5 Direct Antiglobulin Test 25 Adsorption Auto 15 Adsorption Allo 10 Adsorption REST (cold auto) 1 ABO/Rh grouping 5 Antibody Screen 5 PLT Crossmatch (test) 15 Plateletpheresis, HLA matched 5

HPA-1a Antigen screen 1 Molecular genotype (HPA) 1 SARS-CoV-2 Convalescent Plasma 10 SUBTOTAL (Products)

Ordering Period 4: 10/1/26-9/30/27 Leukoc-poor RBC 1400 Red Cells, Washed 15 Red Cells, Irradiated 100 Red Cells, Autologous 5 Red Cells, Thawed 6 Red Cells, Directed 5 Fresh Frozen Plasma 300 Platelet, LVDS 405 Platelet, PRT 5 Pooled Cryo 70 RhIg 2 Screening for negative blood per antigen 100 Irradiate Units 100 Screening for CMV negative blood 10 Antibody Identification 25 Enzyme Panel 20 Select Cell Panel 20 Absorption/Elution with Panel 15 Inhibition/Panel 5

Crossmatched Platelet Donor Recruitment 30 Transportation charge for STAT orders 200 STAT off hours surcharge 40 Volume-reduced cellular products 10

Drug study 5 Direct Antiglobulin Test 25

Adsorption Auto 15 Adsorption Allo 10 Adsorption REST (cold auto) 1 ABO/Rh grouping 5 Antibody Screen 5 PLT Crossmatch (test) 15 Plateletpheresis, HLA matched 5

HPA-1a Antigen screen 1 Molecular genotype (HPA) 1 SARS-CoV-2 Convalescent Plasma 10 SUBTOTAL (Products)